Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-31
DOI
10.3389/fphar.2019.00627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis
- (2019) Yuan-qiang Wang et al. ACTA PHARMACOLOGICA SINICA
- Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
- (2019) Luara A. Batista et al. NEUROSCIENCE LETTERS
- Face validity of a pre-clinical model of operant binge drinking: just a question of speed
- (2018) Jérôme Jeanblanc et al. ADDICTION BIOLOGY
- Regional Brain Volume Changes in Alcohol-Dependent Individuals During Short-Term and Long-Term Abstinence
- (2018) Xiaowei Zou et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review
- (2018) Katie Witkiewitz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
- (2018) Adrián Viudez-Martínez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
- (2018) Mark Thursz et al. JOURNAL OF HEPATOLOGY
- Cannabis for paediatric epilepsy: challenges and conundrums
- (2018) Kerrie-Anne Chen et al. MEDICAL JOURNAL OF AUSTRALIA
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
- (2018) Gustavo Gonzalez-Cuevas et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity
- (2018) Mark D. Underwood et al. Translational Psychiatry
- Pharmacotherapy of alcoholism – an update on approved and off-label medications
- (2017) Michael Soyka et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
- (2017) Ewa Kozela et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors
- (2017) Cristina A.J. Stern et al. NEUROPHARMACOLOGY
- The postnatal 5-HT 1A receptor regulates adult anxiety and depression differently via multiple molecules
- (2017) Chihiro Ishikawa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
- (2017) Yuping Wang et al. Scientific Reports
- A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum
- (2017) A. Musella et al. Scientific Reports
- Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy
- (2016) Karl Mann et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
- (2016) Dale G. Deutsch Frontiers in Pharmacology
- Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression
- (2016) Sudan Prasad Neupane Frontiers in Immunology
- Role of the endocannabinoid system in diabetes and diabetic complications
- (2015) G Gruden et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies
- (2015) Benjamin Rolland et al. CNS Neuroscience & Therapeutics
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
- (2015) Cristoforo Silvestri et al. JOURNAL OF HEPATOLOGY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain
- (2015) Patricia Rivera et al. Frontiers in Cellular Neuroscience
- Postdependent state in rats as a model for medication development in alcoholism
- (2014) Marcus W. Meinhardt et al. ADDICTION BIOLOGY
- Serial longitudinal magnetic resonance imaging data indicate non-linear regional gray matter volume recovery in abstinent alcohol-dependent individuals
- (2014) Timothy C. Durazzo et al. ADDICTION BIOLOGY
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol’s reinforcing effects in male alcohol preferring (P) rats.
- (2014) Catherine F. Moore et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- (2014) Lili Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Immunity and inflammatory signaling in alcoholic liver disease
- (2014) Pranoti Mandrekar et al. Hepatology International
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Global burden of alcoholic liver diseases
- (2013) Jürgen Rehm et al. JOURNAL OF HEPATOLOGY
- Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
- (2013) Vanessa Kappel da Silva et al. MOLECULAR NEUROBIOLOGY
- Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- (2013) M. Ruth Pazos et al. NEUROPHARMACOLOGY
- Widespread and sustained cognitive deficits in alcoholism: a meta-analysis
- (2012) Katherine Stavro et al. ADDICTION BIOLOGY
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol as potential anticancer drug
- (2012) Paola Massi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Is the cardiovascular system a therapeutic target for cannabidiol?
- (2012) Christopher P. Stanley et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Alcohol and the Human Brain: A Systematic Review of Different Neuroimaging Methods
- (2011) Mira Bühler et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells
- (2011) Ana Juknat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
- (2011) Alexandre Louvet et al. HEPATOLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
- (2011) M P Lim et al. Cell Death & Disease
- The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis
- (2010) JM Jamontt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
- (2010) Y Avraham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
- (2010) Fatima Teixeira-Clerc et al. HEPATOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
- (2009) Iddo Magen et al. JOURNAL OF HEPATOLOGY
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
- (2008) Hamish Redmond Ross et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase
- (2008) d. de filippis et al. NEUROGASTROENTEROLOGY AND MOTILITY
- CB2 receptors as new therapeutic targets for liver diseases
- (2007) S Lotersztajn et al. BRITISH JOURNAL OF PHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid
- (2007) P. Massi et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More